Carole L. Yauk , Carmen Cheung , Tara S. Barton-Maclaren , Sherri Boucher , Julie Bourdon-Lacombe , Vinita Chauhan , Matthew Gagné , Zoe Gillespie , Sabina Halappanavar , Michael Honeyman , Steven R. Jones , Elaine Jones-McLean , Sarah Labib , Jane MacAulay , Jocelyn Moore , Martin Paquette , Nicholas Petronella , Souleh Semalulu , Andrew Slot , Alisa Vespa , Cindy L.A. Woodland
{"title":"Toxicogenomic applications in risk assessment at Health Canada","authors":"Carole L. Yauk , Carmen Cheung , Tara S. Barton-Maclaren , Sherri Boucher , Julie Bourdon-Lacombe , Vinita Chauhan , Matthew Gagné , Zoe Gillespie , Sabina Halappanavar , Michael Honeyman , Steven R. Jones , Elaine Jones-McLean , Sarah Labib , Jane MacAulay , Jocelyn Moore , Martin Paquette , Nicholas Petronella , Souleh Semalulu , Andrew Slot , Alisa Vespa , Cindy L.A. Woodland","doi":"10.1016/j.cotox.2019.02.005","DOIUrl":null,"url":null,"abstract":"<div><p>Based on increasing use of mechanistic information in risk assessment, Health Canada's (HC) Task Force on Scientific Risk Assessment established a working group to review and report on the application of toxicogenomics across HC's risk assessment bureaus. The aim was to review current applications and needs for toxicogenomics at HC, to document existing challenges and to promote consistent/coherent risk assessments that consider toxicogenomics. Overall, HC foresees a role for toxicogenomics in risk assessment. To date, select bureaus have incorporated toxicogenomic data, primarily in weight of evidence approaches, to support mode of action analysis. Future efforts to foster networks for increasing expertise/capacity around toxicogenomic data interpretation were viewed as valuable endeavours, and continued support of research to advance applications was recommended.</p></div>","PeriodicalId":37736,"journal":{"name":"Current Opinion in Toxicology","volume":"18 ","pages":"Pages 34-45"},"PeriodicalIF":3.6000,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.cotox.2019.02.005","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Opinion in Toxicology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2468202018300603","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2019/2/21 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"TOXICOLOGY","Score":null,"Total":0}
引用次数: 5
Abstract
Based on increasing use of mechanistic information in risk assessment, Health Canada's (HC) Task Force on Scientific Risk Assessment established a working group to review and report on the application of toxicogenomics across HC's risk assessment bureaus. The aim was to review current applications and needs for toxicogenomics at HC, to document existing challenges and to promote consistent/coherent risk assessments that consider toxicogenomics. Overall, HC foresees a role for toxicogenomics in risk assessment. To date, select bureaus have incorporated toxicogenomic data, primarily in weight of evidence approaches, to support mode of action analysis. Future efforts to foster networks for increasing expertise/capacity around toxicogenomic data interpretation were viewed as valuable endeavours, and continued support of research to advance applications was recommended.
期刊介绍:
The aims and scope of Current Opinion in Toxicology is to systematically provide the reader with timely and provocative views and opinions of the highest qualified and recognized experts on current advances in selected topics within the field of toxicology. The goal is that Current Opinion in Toxicology will be an invaluable source of information and perspective for researchers, teachers, managers and administrators, policy makers and students. Division of the subject into sections: For this purpose, the scope of Toxicology is divided into six selected high impact themed sections, each of which is reviewed once a year: Mechanistic Toxicology, Metabolic Toxicology, Risk assessment in Toxicology, Genomic Toxicology, Systems Toxicology, Translational Toxicology.